A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2006
11/23/2006	US20060263432 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof
11/23/2006	US20060263303 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/23/2006	US20060263301 In situ gelling self-reactive materials for embolization
11/23/2006	US20060263300 Apparatus for producing hyperpolarized noble gas, and nuclear magnetic resonance spectrometer and magnetic resonance imager which use hyperpolarized noble gases
11/23/2006	US20060263299 Effect of substances on sexual function
11/23/2006	US20060263298 Assay
11/23/2006	US20060263297 Ophthalmic measuring method and apparatus
11/23/2006	US20060263296 Diagnostic kit for the measurement of glucose metabolism, method of use, and method for the manufacture thereof
11/23/2006	US20060263294 Tumor targeting agents and uses thereof
11/23/2006	CA2611468A1 Peptides whose uptake by cells is controllable
11/23/2006	CA2608351A1 Effect of substances on sexual function
11/22/2006	EP1724349A1 TIE Ligand Homologues
11/22/2006	EP1724348A2 Molecular tagging system
11/22/2006	EP1723972A1 Vectorisation of dsRNA by cationic particles and their use in a skin model
11/22/2006	EP1723431A1 Hybrid nanoparticles including an ln2o3 core and having bioligands, and method for preparing same
11/22/2006	EP1723252A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
11/22/2006	EP1722833A1 Wound dressings comprising a protein polymer and a polyfunctional spacer
11/22/2006	EP1722825A2 Methods for imaging the lymphatic system using dendrimer-based contrast agents
11/22/2006	EP1722824A1 Optical vascular function imaging system and method for detection and diagnosis of cancerous tumors
11/22/2006	EP1722762A2 Nanocell drug delivery system
11/22/2006	EP1511851A4 Method for identification of biologically active agents
11/22/2006	EP1424083B1 Diagnostic agent for pancreatic exocrine function
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1866025A Method for detecting activity of anti-angiogenesis protein factor or pro-angiogenesis protein factor via zebra fish embryo model and application method thereof
11/22/2006	CN1285582C Thioflavin derivatives for alzheimer's disease premortal diagnosis and starch-like protein in vivo image forming and precaution
11/22/2006	CN1285383C Method and use of closed hydrophilic and lipophilic liquid-phase hollow capsules with cores
11/21/2006	US7139122 System and method for enhancing confocal reflectance images of tissue specimens
11/21/2006	US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006	US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006	US7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
11/21/2006	US7138136 Biocompatible particles between 0.1 and 1.0 microns in diameter, that are loaded with one or more drugs and which are crosslinked together to form agglomerates
11/21/2006	US7138106 Compositions for use in embolizing blood vessels
11/21/2006	US7138104 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
11/21/2006	US7138103 Completitive binding
11/16/2006	WO2006122035A2 Method for treating central pain syndrome or for inducing centrally generated pain in an animal model
11/16/2006	WO2006121631A2 Real time imaging during solid organ transplant
11/16/2006	WO2006120444A1 Responsive luminescent lanthanide complexes
11/16/2006	WO2006119994A2 Method for producing albumin conjugates comprising an x-ray contrast medium as the active substance
11/16/2006	WO2006119968A2 Compositions and methods using microspheres and non-ionic contrast agents
11/16/2006	WO2006119645A1 Marker device for x-ray, ultrasound and mr imaging
11/16/2006	WO2006087144A3 Contrast agents for nuclear spin tomography carried out by means of overhauser effect
11/16/2006	WO2006034485A3 Treatment for age-related cognitive decline and other conditions
11/16/2006	US20060258866 Carboxylic derivates
11/16/2006	US20060258566 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/16/2006	US20060257842 Cryopreservation media and molecules
11/16/2006	US20060257326 Methods and formulations for delivery of pharmacologically active agents
11/16/2006	US20060257322 Pharmaceutical agents that contain fluoroalkyl-containing metal complexes and epothilones
11/16/2006	US20060257321 Ultrasound contrast agents and methods of making and using them
11/16/2006	US20060257320 Biodegradable polyacetals and methods
11/16/2006	US20060257319 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy
11/16/2006	DE102005038304A1 Verfahren zum Öffnen von Hohlstrukturen aus magnetischen Nanopartikeln A method for opening of hollow structures of magnetic nanoparticles
11/16/2006	DE102005021846A1 Verfahren zur Herstellung von Albumin-Konjugaten mit einem Röntgenkontrastmittel als Wirkstoff Process for the preparation of albumin conjugates with an X-ray contrast agent as an active ingredient
11/16/2006	DE102005020379A1 Verfahren zur Abbildung der Mikrostruktur der Lunge und eine Vorrichtung hierfür A method for imaging the microstructure of the lung and an apparatus therefor
11/16/2006	CA2607694A1 Method for producing albumin conjugates comprising an x-ray contrast medium as the active substance
11/16/2006	CA2607281A1 Anti-cd19 antibody therapy for autoimmune disease
11/16/2006	CA2607228A1 Compositions and methods using microspheres and non-ionic contrast agents
11/16/2006	CA2579914A1 Marker device for x-ray, ultrasound and mr imaging
11/15/2006	EP1720894A1 Assay for ligands of the ecdysone receptor
11/15/2006	EP1720521A2 Improved efficacy and safety of targeted particulate agents with decoy systems
11/15/2006	EP1720516A2 Expandable gastric retention device
11/15/2006	EP1720498A2 Abuse potential reduction in abusable substance dosage form
11/15/2006	EP1412383B1 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
11/15/2006	CN1863507A Remedy or diagnostic for inflammatory disease containing target-directing liposome
11/15/2006	CN1863483A Contrast media for use in medical and diagnostic procedures and methods of using the same
11/15/2006	CN1861661A Polyoxyethylene kind block polymer ligand and synthesizing process thereof
11/15/2006	CN1861196A Application of hydroxy coriaria toxin for preparing epileptogenic agent to prepare epileptic animal model
11/15/2006	CN1860990A Biological simulation system and recording medium
11/14/2006	US7135611 Animal models for use in identifying modulators for treatment of obesity
11/14/2006	US7135198 Preparation for oral administration
11/14/2006	US7135192 Lipid, Dna complex with detectable labels
11/14/2006	US7135177 Immunoliposomes that optimize internalization into target cells
11/14/2006	US7135162 Agent for diagnosing and treating malignant tumors
11/14/2006	CA2230228C Fluorescence lifetime-based imaging and spectroscopy in tissues and other random media
11/09/2006	WO2006119464A1 Predicting treatment response in cancer subjects
11/09/2006	WO2006119438A2 Methods for measuring cholesterol metabolism and transport
11/09/2006	WO2006100305A3 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging
11/09/2006	WO2006064453A3 Targeting agents for molecular imaging
11/09/2006	WO2006051153B1 Methods and devices for facile fabrication of nanoparticles and their applications
11/09/2006	WO2005049091A3 Antibody-targeted nanoparticulate active agent delivery
11/09/2006	WO2004069153A3 Apparatus, system and method for generating bubbles on demand
11/09/2006	US20060252923 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
11/09/2006	US20060252674 Methods for pretreating a subject with extracorporeal photopheresis
11/09/2006	US20060251583 diethylenetriamine pentaacetic acid (DTPA); for treating vascular restenosis, kidney disorders
11/09/2006	US20060251582 Compositions and methods using microspheres and non-ionic contrast agents
11/09/2006	US20060251581 Method for treatment of uterine fibroid tumors
11/09/2006	US20060251580 Lectin conjugates
11/09/2006	US20060251577 Orally administering a positive contrast agent comprising meglumine diatrizoate, sodium diatrizoate; simethicone; famotidine; and aspartame; applying computerized axial tomography to the patient approximately 50 minutes afterwards; side effect reduction, bulk storage, bioavailability
11/09/2006	US20060251576 Methods for measuring cholesterol metabolism and transport
11/09/2006	US20060248944 Method to determine the spatial distribution of magnetic particles and magnetic particle administering compositions
11/09/2006	DE10361140B4 Verfahren zur Herstellung von dendritischen Trimesinsäuretriamiden, dabei verwendete Diethylentriaminderivate und Verwendung der Diethylentriaminderivate A process for the preparation of dendritic Trimesinsäuretriamiden, Diethylentriaminderivate used therein and using the Diethylentriaminderivate
11/09/2006	CA2606447A1 Methods for measuring cholesterol metabolism and transport
11/08/2006	EP1719754A1 DTPA derivatives and metal complexes therof, and radiation source and contrast agent including the metal complexes
11/08/2006	EP1719529A1 Contrast medium for thrombus formation
11/08/2006	EP1718341A2 Articles comprising magnetic material and bioactive agents
11/08/2006	EP1718282A1 Methods and compositions for imaging
11/08/2006	CN1860132A Inhibitors of extracellular hsp90
11/08/2006	CN1859927A A method of evaluating organ function
11/08/2006	CN1859843A Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications

1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 354